About Auregen

Replacing Missing or Dysfunctional Tissues

Our approach enables replacement without rejection risk or dependence on single donor supply, while reflecting the beauty, complexity, and adaptability of human evolution.

Collage including an image of an shoulder in one circle and abstract scientific texture in another circle, with a line drawing connecting them

Driven by Exploration Inspired by humanity

Abstracted illustration of the side profile of a man's head using pieces of a photograph and line drawing

We are #AUREGENATORS—and each day we discover a new way forward.

At Auregen, we are boldly creating a new era of never-before-dreamed of medical advances, replacing the parts of ourselves we have lost to accident, disease, or nature for whole bodies, full lives, and infinite human potential. Founded in Europe over a decade ago, we bring together ingenious technologies, visionary scientists, and life science leadership to pursue new possibilities in human tissue engineering—all in a culture that's open, precise, genuine, and driven to succeed. With a first indication for microtia rapidly moving forward in clinical development, we believe we can offer patients new hope and new potential for life-like, life-long solutions to serious medical conditions that reflect the beauty, complexity, and evolutionary genius of human biology.

Leadership

Jason Meyenburg
,
Chief Executive Officer, Board Director

Jason Meyenburg joined Auregen Bio as Chief Executive Officer in June of 2022. He has more than 20 years of experience in developing and commercializing therapies for patients with serious conditions.

Jason Meyenburg
,
Chief Executive Officer, Board Director

Jason Meyenburg joined Auregen Bio as Chief Executive Officer in June of 2022. He has more than 20 years of experience in developing and commercializing therapies for patients with serious conditions.

José Manuel Otero
,
PhD
Chief Technical Officer

José Manuel (Manny) Otero, PhD brings over 20 years of industry experience in vaccines and complex biologics development, across pre-clinical, clinical-stage and commercial product portfolios.

José Manuel Otero
,
PhD
Chief Technical Officer

José Manuel (Manny) Otero, PhD brings over 20 years of industry experience in vaccines and complex biologics development, across pre-clinical, clinical-stage and commercial product portfolios.

Pete Weber
,
MD
Chief Medical Officer

Pete brings 25 years of multidisciplinary expertise in product development, research, and clinical, focusing on small molecules, gene therapy, device, oncology, neurology, and otolaryngology treatment innovations.

Pete Weber
,
MD
Chief Medical Officer

Pete brings 25 years of multidisciplinary expertise in product development, research, and clinical, focusing on small molecules, gene therapy, device, oncology, neurology, and otolaryngology treatment innovations.

Gregg Beloff
,
JD, MBA
Interim Chief Financial Officer

Gregg Beloff is an accomplished life science executive officer with nearly 30 years of experience leading finance and operations for both venture-backed start-ups and publicly held companies.

Gregg Beloff
,
JD, MBA
Interim Chief Financial Officer

Gregg Beloff is an accomplished life science executive officer with nearly 30 years of experience leading finance and operations for both venture-backed start-ups and publicly held companies.

A Gurnet Point Capital Company

Magnifying glass line drawing

We believe in "How do we make it possible?"

At Auregen, we are boldly creating a new era of potentially life-changing medical advances. This mission to redefine human health demands the best of ourselves—and each other.

Paper airplane line drawing

Driven by courage and intent

Because every step we take has never been taken before. And each day we work together reveals new knowledge—and new potential for human health.

Puzzle line drawing

We are #AUREGENATORS

We are #AUREGEN-ATORS

Working at Auregen is for people with a deep commitment to the future of medicine, whose work, approach and drive is an extension of themselves.

Fire line drawing

Igniting the medicine within

What we pursue is more than therapeutics—we seek to empower each individual to access their innate ability to heal.